NewsRoom Articles - Page 1332 of 1390

ThursdayDec 08, 2016 12:30 pm

UGE International (UGEIF) Starts Presentation at LD Micro Main Event

With more than 330MW of experience worldwide, UGE International's (OTCQB: UGEIF) full-service energy solutions are designed to help commercial and industrial clients become more competitive through the low cost of distributed renewable energy. The company's services are driven through a solutions-based approach, engineering expertise and a focus on value. UGE is ranked among North America's Top Solar Developers by Solar Power World. For more information, visit the company's website at www.ugei.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…

ThursdayDec 08, 2016 12:30 pm

Theralase Technologies (TLTFF) Starts Presentation at LD Micro Main Event

Theralase Technologies (OTC PINK:TLTFF), through its Therapeutic Laser Technology division, focuses on the design, manufacture, marketing and distribution of patented super-pulsed laser technology designed to eliminate pain, reduce inflammation, and accelerate tissue healing for numerous nerve, muscle and joint conditions. The company's Photo Dynamic Therapy division researches and develops specially designed molecules called photodynamic compounds, which localize to cancer cells and then when laser light activated, effectively destroy them. For more information, visit the company's website at www.theralase.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As…

ThursdayDec 08, 2016 12:30 pm

Aytu BioScience (AYTU) Starts Presentation at LD Micro Main Event

Aytu BioScience (OTCQX: AYTU) is a commercial-stage specialty pharmaceutical company focused on novel products in the field of urology. Aytu's current product portfolio consists of Natesto®, the first and only FDA-approved nasal formulation of testosterone for men with low testosterone; ProstaScint®, the only FDA-approved imaging agent specific to prostate specific membrane antigen (PSMA) for prostate cancer detection and staging; and Primsol®, the only FDA-approved trimethoprim-only oral solution for urinary tract infections. The company is developing MiOXSYS®, a semen analysis system with the potential to become a standard of care for the diagnosis and management of male infertility caused by oxidative…

ThursdayDec 08, 2016 12:00 pm

Pressure Biosciences (PBIO) Starts Presentation at LD Micro Main Event

Pressure Biosciences (OTC: PBIO) develops pressure cycling technology (PCT) solutions in the United States. Its PCT technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant, and microbial sources. The company offers Barocycler instrumentations, including Barocycler NEP3229, Barocycler NEP2320, Barocycler HUB440, PCT MicroTube Adapter Kit, The Shredder SG3, Barocycler HUB880, Barozyme HT48, BaroFlex 8-well Processing Strips, and PCT-HD laboratory instrumentation. For more information, visit the company's website at www.pressurebiosciences.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press…

ThursdayDec 08, 2016 12:00 pm

Bel Fuse (BELFB) Starts Presentation at LD Micro Main Event

Bel Fuse (NASDAQ: BELFB) designs, manufactures, markets and sells products used in the networking, telecommunication, high-speed data transmission, commercial aerospace, military, broadcasting, transportation and consumer electronic industries worldwide. It offers magnetic products, such as integrated connector modules; power transformers; SMD power inductors and SMPS transformers; and telecom discrete components. The company also provides power solutions and protection products comprising front-end power supplies. For more information, visit the company's website at www.belfuse.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company…

ThursdayDec 08, 2016 12:00 pm

Signal Bay (SGBY) Starts Presentation at LD Micro Main Event

Signal Bay (OTC: SGBY) provides advisory, management and analytical testing services to the legalized cannabis industry in the United States. The company offers industry research; business and market intelligence; and advisory and consulting services, including license application support, regulatory compliance, market forecasts and operational insights. It also publishes industry information through online media, research reports and publications, and operates CANNAiQ.com, a business to business information portal, as well as MarijuanaMath.com, a general interest informational website. For more information, visit the company's website at www.signalbay.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

ThursdayDec 08, 2016 11:30 am

The Female Health Company (FHCO) Starts Presentation at LD Micro Main Event

The Female Health Company (NASDAQ:FHCO) is a specialty pharmaceutical and medical device company focused on pharmaceutical products that qualify for the 505(b)(2) FDA regulatory pathway that can result in more rapid approval than a full new drug application. Through its Global Public Health Division, the company manages the global public health sector FC2 Female Condom® (FC2) business, marketing FC2 to a variety of entities that aim to support and improve the well-being of women worldwide. Veru Healthcare manages the development and commercialization of pharmaceutical and medical device products for men's and women's health and oncology, as well as commercialization of…

ThursdayDec 08, 2016 11:30 am

ClearSign Combustion (CLIR) Starts Presentation at LD Micro Main Event

ClearSign Combustion (NASDAQ: CLIR) designs and develops products and technologies designed to improve key performance characteristics of combustion systems, including emissions and operational performance, energy efficiency and overall cost-effectiveness. The company's patented Duplex™ and Electrodynamic Combustion Control™ platform technologies enhance the performance of combustion systems in a broad range of markets, including the chemical, petrochemical, refinery, power and commercial/industrial boiler industries. For more information, visit the company's website at www.clearsign.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with…

ThursdayDec 08, 2016 11:00 am

US Nuclear (UCLE) Starts Presentation at LD Micro Main Event

US Nuclear (OTCBB: UCLE), through its subsidiaries, operates two nuclear radiation detection companies, Overhoff Technology Corp. and Optron Scientific Company Inc. US Nuclear Corp designs, manufactures and markets branded, full line radiation detection and specialized advanced tritium technology for the nuclear energy industry and for emerging technological processes such as Thorium and Molten Salt (MSR) reactor technologies both domestically and internationally. US Nuclear customers include United States Government Agencies, the U.S. military, homeland security, scientific laboratories, universities, hospitals and nuclear reactor facilities in the United States, China, Canada, South Korea, Argentina, Russia and others. For more information, visit the company's…

ThursdayDec 08, 2016 11:00 am

Marina Biotech (MRNA) Starts Presentation at LD Micro Main Event

Marina Biotech (OTC: MRNA) discovers and develops nucleic acid-based therapeutics for rare and orphan diseases. The company's portfolio includes single and double-stranded nucleic acid therapeutics, including siRNAs, microRNA mimics, antagomirs, and antisense compounds that are intended to trigger various RNA-based mechanisms of actions, such as RNA interference, microRNA replacement therapy, microRNA inhibition, and mRNA translational inhibition. It also focuses on patients with familial adenomatous polyposis, a rare hereditary disease; myotonic dystrophy, a disease that affects muscles and other organs in the body; and Duchenne muscular dystrophy. For more information, visit the company's website at www.marinabio.com. About NetworkNewsWire NetworkNewsWire (NNW) provides…